H
Howard A. Cohen
Researcher at Temple University
Publications - 81
Citations - 4286
Howard A. Cohen is an academic researcher from Temple University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 29, co-authored 81 publications receiving 4011 citations. Previous affiliations of Howard A. Cohen include Lenox Hill Hospital & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock
TL;DR: In patients presenting within 24 hours of the development of CGS, TandemHeart significantly improves hemodynamic parameters, even in patients failing IABP, and larger-scale studies are required to assess the influence of improved hemodynamics on survival.
Journal ArticleDOI
Volume-to-creatinine clearance ratio : A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention
Warren K. Laskey,Charles Jenkins,Faith Selzer,Oscar C. Marroquin,Robert L. Wilensky,Ruchira Glaser,Howard A. Cohen,David R. Holmes,Nhlbi Dynamic Registry Investigators +8 more
TL;DR: A V/CrCl ratio >3.7 was a significant and independent predictor of an early abnormal increase in serum creatinine after PCI in this unselected patient population.
Journal ArticleDOI
Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986 The National Heart, Lung, and Blood Institute Registries
David O. Williams,Richard Holubkov,Wanlin Yeh,Martial G. Bourassa,Mahdi Al-Bassam,Peter C. Block,Paul Coady,Howard A. Cohen,Michael J. Cowley,Gerald Dorros,David P. Faxon,David R. Holmes,Alice K. Jacobs,Sheryl F. Kelsey,Spencer B. King,Richard K. Myler,James Slater,Vladimir Stanek,Helen Vlachos,Katherine M. Detre +19 more
TL;DR: Although Dynamic Registry patients had more unstable and complex coronary disease than those in the 1985–1986 Registry, their rate of procedural success was higher whereas rates of complications and subsequent CABG were lower.
Journal ArticleDOI
Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks.
Carlos E. Ruiz,Vladimir Jelnin,Itzhak Kronzon,Yuriy Dudiy,Raquel del Valle-Fernández,Bryce Einhorn,Paul T.L. Chiam,Claudia Martinez,Rocio Eiros,Gary S. Roubin,Howard A. Cohen +10 more
TL;DR: Percutaneous closure of symptomatic paravalvular leaks, facilitated by integrated imaging modalities has a high rate of acute and long-term success and appears to be effective in managing symptoms of heart failure and hemolytic anemia.
Journal ArticleDOI
Clinical Progression of Incidental, Asymptomatic Lesions Discovered During Culprit Vessel Coronary Intervention
Ruchira Glaser,Faith Selzer,David P. Faxon,Warren K. Laskey,Howard A. Cohen,James Slater,Katherine M. Detre,Robert L. Wilensky +7 more
TL;DR: Approximately 6% of PCI patients will have clinical plaque progression requiring nontarget lesion PCI by 1 year, and greater coronary artery disease burden confers a significantly higher risk for clinical plaque progress.